The Latest Breaking News on Pharma

Edinburgh-based start-up will now be able to accelerate development of its life sciences technology

Catalent stock launched higher Monday on a rumor that Danaher could acquire it in a bid to compete with Thermo Fisher Scientific.

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….

Neurocrine reported soaring fourth-quarter profit Monday and issued in-line guidance for Ingrezza. But NBIX stock toppled.

‘Lead5050 Index provides a comprehensive snapshot of how well employers tackle the gender pay gap’

Shares in Little Green Pharma and Emyria are up by more than 40 per cent as both announce plans to take advantage of Australia's "world-leading" drug decision.

A total of 55 patients reported adverse effects after using EzriCare and Delsam Pharma's Artificial Tears, including eye infections, permanent loss of vision, and a death with a bloodstream infection

Eloise Hendy asks psychologists and doctors if the viral wave of vaccine-induced symptoms is real or faked or something else entirely

Australia in its progressive drug policy era????? Here for it.

People in NSW town are being urged to stay away from downed power lines. This blog is now closed